Trial intelligence / Profile preview

Indacaterol vs Tiotropium in Biomass COPD (EMERAL)

NCT02473237Phase 4Completed

Sponsor
Instituto Nacional de Enfermedades Respiratorias
Start
Apr 2013
Primary completion
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of indacaterol in chronic obstructive pulmonary disease (COPD), sponsored by Instituto Nacional de Enfermedades Respiratorias. Started Apr 2013; status: completed.

02

Drugs

indacaterol
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT02473237.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02473237.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call